BMEZ: NAV Decline Continues And Underperforms Peers
Source: SeekingAlpha
2025-11-28 11:41:30 ET
Overview
The healthcare sector continues to lag behind the rest of the market, which has caused funds, like the BlackRock Health Sciences Term Trust ( BMEZ ), to see its performance suffer. When I previously covered BMEZ, I issued a Sell rating due to the fact that the fund was paying out more than it actually earned in income. Since my last coverage, BMEZ has released an updated semi-annual report, which prompted me to revisit the fund's performance and outlook going forward....
Read the full article on Seeking Alpha
For further details see:
BMEZ: NAV Decline Continues And Underperforms Peers
BlackRock Health Sciences Term Trust of Beneficial Interest
NASDAQ: BMEZ
BMEZ Trading
0.26% G/L:
$15.27 Last:
208,538 Volume:
$15.30 Open:
BMEZ Latest News
May 19, 2026 05:00:45 am
The Interest Rate "Surprise" Everyone's Ignoring (and the 10.3% Dividend That Profits From it)
$200,928,581
12,560,000
N/A
118
N/A
Asset Management Services
Finance
US
Wilmington
